Company Filing History:
2 out of 2,968 
2 out of 1,384 
Years Active: 2025
Title: David A. Harris: Innovator in Metabolic Disorder Treatments
Introduction
David A. Harris is a notable inventor based in Arlington, MA (US), recognized for his contributions to the field of metabolic disorder treatments. With a total of 2 patents, he has made significant strides in developing innovative solutions for diabetes and obesity.
Latest Patents
Harris's latest patents include "Synthetic derivatives of cholic acid 7-sulfate and uses thereof." This patent outlines the discovery of cholic acid 7-sulfate as a potential treatment for diabetes. The methods described involve administering a compound of Formulae (I)-(XVII) to treat various metabolic disorders and inflammatory diseases. Another patent focuses on methods of increasing the amount of cholic acid-7-sulfate (CA7S) in a subject, providing compositions and kits for the treatment of diabetes and obesity.
Career Highlights
Throughout his career, David A. Harris has worked with prestigious institutions such as Harvard College and Brigham and Women's Hospital, Inc. His research has contributed to the understanding and treatment of complex metabolic conditions.
Collaborations
Harris has collaborated with notable colleagues, including Abigail Sloan Devlin and Snehal N. Chaudhari, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
David A. Harris stands out as an innovator in the field of metabolic disorder treatments, with his patents paving the way for new therapeutic approaches. His work continues to influence the medical community and offers hope for those affected by diabetes and obesity.